Cover Image
Market Research Report
Product code 
1028857

Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth And Change To 2030

Published: Pre-Order | The Business Research Company | 175 Pages | Delivery time: 2-10 business days

Price

Back to Top
Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth And Change To 2030
Published: Pre-Order
The Business Research Company
Content info: 175 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global drugs for immunotherapy market.

The report focuses on the drugs for immunotherapy market which is experiencing strong growth. The report gives a guide to the drugs for immunotherapy market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the drugs for immunotherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs for Immunotherapy Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Interferons; Interleukins; Vaccines; Checkpoint Inhibitors; Others

2) By Therapy Area: Cancer; Autoimmune & Inflammatory Diseases; Infectious Diseases; Others

3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd; Novartis AG; Amgen; AbbVie; Merck & Co.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents
Product Code: h881

Table of Contents

1. Executive Summary

2. Drugs for Immunotherapy Market Characteristics

3. Drugs for Immunotherapy Market Trends And Strategies

4. Impact Of COVID-19 On Drugs for Immunotherapy

5. Drugs for Immunotherapy Market Size And Growth

  • 5.1. Global Drugs for Immunotherapy Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Drugs for Immunotherapy Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Drugs for Immunotherapy Market Segmentation

  • 6.1. Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal antibodies
  • Interferons
  • Interleukins
  • Vaccines
  • Checkpoint Inhibitors
  • Others
  • 6.2. Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer
  • Autoimmune & Inflammatory Diseases
  • Infectious Diseases
  • Others
  • 6.3. Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

7. Drugs for Immunotherapy Market Regional And Country Analysis

  • 7.1. Global Drugs for Immunotherapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Drugs for Immunotherapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Drugs for Immunotherapy Market

  • 8.1. Asia-Pacific Drugs for Immunotherapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Drugs for Immunotherapy Market

  • 9.1. China Drugs for Immunotherapy Market Overview
  • 9.2. China Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Drugs for Immunotherapy Market

  • 10.1. India Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Drugs for Immunotherapy Market

  • 11.1. Japan Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Drugs for Immunotherapy Market

  • 12.1. Australia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Drugs for Immunotherapy Market

  • 13.1. Indonesia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Drugs for Immunotherapy Market

  • 14.1. South Korea Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Drugs for Immunotherapy Market

  • 15.1. Western Europe Drugs for Immunotherapy Market Overview
  • 15.2. Western Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Drugs for Immunotherapy Market

  • 16.1. UK Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Drugs for Immunotherapy Market

  • 17.1. Germany Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Drugs for Immunotherapy Market

  • 18.5. France Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Drugs for Immunotherapy Market

  • 19.1. Eastern Europe Drugs for Immunotherapy Market Overview
  • 19.2. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Drugs for Immunotherapy Market

  • 20.1. Russia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Drugs for Immunotherapy Market

  • 21.1. North America Drugs for Immunotherapy Market Overview
  • 21.2. North America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Drugs for Immunotherapy Market

  • 22.1. USA Drugs for Immunotherapy Market Overview
  • 22.2. USA Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Drugs for Immunotherapy Market

  • 23.1. South America Drugs for Immunotherapy Market Overview
  • 23.2. South America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Drugs for Immunotherapy Market

  • 24.1. Brazil Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Drugs for Immunotherapy Market

  • 25.1. Middle East Drugs for Immunotherapy Market Overview
  • 25.2. Middle East Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Drugs for Immunotherapy Market

  • 26.1. Africa Drugs for Immunotherapy Market Overview
  • 26.2. Africa Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Drugs for Immunotherapy Market Competitive Landscape And Company Profiles

  • 27.1. Drugs for Immunotherapy Market Competitive Landscape
  • 27.2. Drugs for Immunotherapy Market Company Profiles
    • 27.2.1. F. Hoffmann-La Roche Ltd
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Amgen, Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. AbbVie, Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Merck & Co., Inc
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Drugs for Immunotherapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Drugs for Immunotherapy Market

30. Drugs for Immunotherapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer